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Abstract.
Summary: Building classification models that predict a binary class label on the basis of high
dimensional multi-omics datasets poses several challenges, due to the typically widely differing
characteristics of the data layers in terms of number of predictors, type of data, and levels of noise.
Previous research has shown that applying classical logistic regression with elastic-net penalty to
these datasets can lead to poor results (Liu et al., 2018). We implement a two-step approach to
multi-omic logistic regression in which variable selection is performed on each layer separately and a
predictive model is then built using the variables selected in the first step. Here, our approach is
compared to other methods that have been developed for the same purpose, and we adapt existing
software for multi-omic linear regression (Zhao and Zucknick, 2020) to the logistic regression setting.
Extensive simulation studies show that our approach should be preferred if the goal is to select
as many relevant predictors as possible, as well as achieving prediction performances comparable
to those of the best competitors. Our motivating example is a cardiometabolic syndrome dataset
comprising eight ’omic data types for 2 extreme phenotype groups (10 obese and 10 lipodystrophy
individuals) and 185 blood donors. Our proposed approach allows us to identify features that
characterise cardiometabolic syndrome at the molecular level.
Availability: R code is available at https://github.com/acabassi/logistic-regression-for-multi-omic-data.
Contact: alessandra.cabassi@mrc-bsu.cam.ac.uk, paul.kirk@mrc-bsu.cam.ac.uk.
1 Introduction
In this work, we focus on the problem of making predictions for a binary variable using multiple
high-dimensional ’omic layers. In the context of precision medicine, this can be used for example, to
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sort patients into low- and high-risk groups for a certain disease, as we show in our application. It
is well established that building predictive models for datasets with a large number of variables p
compared to the number of statistical units n requires extra care, since classical statistical methods
designed for large n small p situations may fail or overfit the data. Combining multiple large p, small
n datasets of different types raises new questions. The large p small n problem is exacerbated by
the presence of multiple datasets. Moreover, different datasets can have different scales, number of
covariates, and fractions of covariates that are associated with the outcome of interest. Multi-omic
datasets can also have varying numbers of correlated variables both within and across ’omic layers.
Furthermore, it may be important to balance the predictive performance of the model with the
stability of the set of selected variables (Kirk et al., 2010, 2013, 2011, Meinshausen and Bühlmann,
2010).
Many variable selection and binary predictive models exist (see Section 2.2 for a brief review).
Here, we focus on penalised likelihood approaches, which are scalable, widely used and have the
advantage of having efficient implementations available. In particular, we make use of the elastic-net,
which allows us to be flexible in terms of how we treat correlations among the variables. In this
context, multiple studies have shown that it can be beneficial to apply different penalties to each
’omic layer (Boulesteix et al., 2017, Liu et al., 2018). The problem with these approaches is then
how to choose the values of the penalty parameters. Indeed, while classical penalised likelihood
approaches employ cross-validation to select the parameters of the model, the computational cost can
become prohibitive when the number of parameters increases. For this reason, Zhao and Zucknick
(2020) resort to a Gaussian process approximation to the prediction error surface in order to more
efficiently find the optimal parameters of the model. Another important question is whether or not
one wants, or needs, to ensure that all layers contribute to the predictive model, irrespective of their
relative dimensionality.
In our motivating example, we are interested in finding a molecular signature of cardiometabolic
disease in each of the eight available layers. For this reason, we propose a two-step approach in
which the variable selection step is performed on each ’omic layer separately, so that the signal from
smaller datasets is not obscured by those of the larger ones. In the second step, all the selected
variables are stacked together to fit a ridge-penalised logistic regression model. We compare this
approach to simply applying elastic-net on the full dataset, to a newly developed integrative method
that fits a regression model on all data types together, but assigning different penalty factors to
each of them (Zhao and Zucknick, 2020), and to a simple, univariate approach.
We consider a wide range of simulation studies. In each simulation setting there are two data
types with varying characteristics, as well as a smaller data type that only contains features that
are known to be associated with the outcome of interest, and therefore are not penalised. In
real data applications, this corresponds to having two ’omic datasets and a small set of clinical
parameters. The simulation studies show that, depending on the goal of the analysis, different
integrative methods should be preferred. If the objective is to make accurate predictions and, at the
same time, identify the highest possible number of variables that are relevant for the problem at
hand, then our approach is the most suitable.
Our motivating example is a multi-omic dataset collected and analysed in Seyres et al. (2020) to
understand and identify the molecular characterisation of cardiometabolic syndrome. We analyse
eight different types of ’omic data from 185 blood donors, as well as 10 obese and 10 lipodystrophy
individuals. As in Seyres et al. (2020), we use these data to identify putative signatures of
cardiometabolic syndrome and build a predictive model to determine the probability of belonging to
the obese group. Here, we go beyond the analysis previously performed by investigating the impact
of the choice of the elastic-net parameter on the estimated probabilities and the variables selected,
by comparing to a rank aggregation approach, and by additionally constructing a predictive model
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to determine the probability of belonging to the lipodystrophy group.
2 Methods
First, we briefly recall the basics of penalised logistic regression in Section 2.1. Then, a review of the
predictive models of this type that have been used to integrate multiple ’omic datasets is given in
Section 2.2. In Section 2.3 we give the details of the EPSGO (efficient parameter selection via global
optimisation) algorithm, which is extensively used in the rest of this work. In Section 2.4 we suggest
two novel approaches to integrate multiple ’omic datasets in the framework of logistic regression.
2.1 Penalised logistic regression
In traditional logistic regression settings, one has a dataset X ∈ RN×P made by N observations xn,
n = 1, . . . , N , for which a set of p variables has been measured, and by a set of binary responses
y = [y1, . . . , yN ] ∈ {0, 1}N , one for each observation in X. The goal is then to build a model that
predicts the probability that the response y corresponding to a new observation x is equal to one
(Cramer, 2002, Hastie et al., 2009). This is done via the logistic function
Pr(Y = 1|x) = e
β0+βx
1 + eβ0+βx , (1)
where β0 and β = [β1, . . . , βp] are the so-called regression coefficients. In particular, β0 is the
intercept of the model and each βp is the coefficient corresponding to the pth variable (i.e. column)
in X.
In the presence of large numbers of predictors, the estimates of the regression coefficients β0
and β given by solving the optimisation problem above are highly variable. To avoid this problem
shrinkage methods are often used. In what follows, we focus on the elastic-net (EN):
min
β0∈R, β∈RP
− l(X,y;β0,β) + λ [(1− α)‖β‖2 + α‖β‖1] (2)
Here, ‖ · ‖1 and ‖ · ‖2 represent the l1 and l2 norms respectively, α is the weight assigned to
the l1 penalty, and 1 − α is the weight assigned to the l2 penalty, and λ is a parameter used to
determined the strength of the penalty (Zou and Hastie, 2005). The parameter λ is usually selected
via cross-validation (CV; Kohavi et al., 1995), while α can either be tuned using CV or chosen so as
to give the desired number of selected variables.
2.2 Literature review
As mentioned in the introduction, the integration of multiple ’omic datasets in the context of
prediction cannot be done via the classical methods for penalised logistic regression such as those
presented in the previous section, but requires the development of novel statistical methods. The
main ideas behind the methods available in the literature are illustrated below. For simplicity, we
refer to the different ’omic datasets as data layers.
One of the first examples of predictive models for multi-omic datasets is that of Zhao et al.
(2015). First, they apply LASSO regression to a multi-omic dataset in order to do variable selection
in each layer separately, then they use the selected variables in a l2-penalised Cox regression model.
Boulesteix et al. (2017) instead developed a bespoke penalised regression method for multi-omic
data. It is similar to a LASSO regression, but it assigns a different penalty to each layer. This
approach is called IPF-LASSO: integrative LASSO with penalty factors. Denoting by M the number
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of data layers and by Xm each layer’s data matrix, where m = 1, . . . ,M , Boulesteix et al., like us,
are interested in those situations where each layer has observations for the same N individuals and
a different set of Pm features, i.e. Xm ∈ RN×Pm and the rows in each matrix Xm correspond to the
same statistical units. Let β(m)j be the regression coefficient for the jth feature of the mth layer.
IPF-LASSO tries to find the optimal set of coefficients β = [β(1)1 , . . . , β
(1)
P1
, . . . , β
(M)
1 , . . . , β
(M)
PM
] such
that
min
β0∈R, β∈RP1+···+PM
− l(X,y;β0,β) +
M∑
m=1
λm‖β(m)‖1. (3)
Boulesteix et al. suggest to choose the penalty parameters by a double CV approach. First, for
each of candidate set of penalties λ2, . . . , λM , all the predictors are rescaled as follows:
x∗ij =
x
(m)
ij
λm/λ1
, (4)
where i = 1, . . . , n, j = 1, . . . , Pm, and m = 1, . . . ,M (note that the features in the first layer remain
unchanged). Then, thanks to this, the same penalty λ1 can be applied to all the scaled variables, and
the parameter λ1 is estimated via CV in the standard way. The candidate set of penalties λ2, . . . , λM
that gives the best prediction performance is then selected together with the corresponding value
of λ1 found via CV. How to choose the candidate penalty factors λ2, . . . , λM remains an open
question; the authors pick a grid of predefined values 2k, k = −a,−(a− 1), . . . , 0, . . . , a− 1, a where
a is an integer that varies between 3 and 6 depending on the application. The limitation of this
approach is that the computational burden increases very quickly with the number of layers M , as
the number of candidate sets grows exponentially with M , making it impossible to explore a large
set of possibilities for the penalty terms. Boulesteix et al. apply this method to a wide range of
simulation settings, as well as real datasets on acute myeloid leukaemia (The Cancer Genome Atlas
Research Network, 2013) and breast cancer (Hatzis et al., 2011) where the outcomes are overall
survival time and relapse-free survival time respectively.
Similarly to what Boulesteix et al. did for LASSO, Liu et al. (2018) show that, if the number of
informative features is not the same in each dataset, fitting EN regression models with different
penalties for each dataset yields better predictions than having a single global penalty. They do so
by defining a multi-tuning parameter elastic-net regression (MTP-EN). For simplicity, let
N(β) = (1− α)‖β‖2 + α‖β‖1. (5)
Then, the regression parameters of MTP-EN are found by solving the penalised regression problem
min
β0∈R, β∈RP1+···+PM
− l(X,y;β0,β) + λ1N(β1) + · · ·+ λMN(βM ) (6)
This corresponds to fitting a weighted EN model
min
β0∈R, β∈RP1+···+PM
− l(X,y;β0,β) + λ1Nw(β) (7)
where
Nw(β) = α
P1+···+PM∑
p=1
wp|βp|+ (1− α)
P1+···+PM∑
p=1
wpβ
2
p , (8)
and the weights wp are w = [1, . . . , 1, λ2/λ1, . . . , λ2/λ1, . . . , λM/λ1, . . . , λM/λ1].
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Both IPF-LASSO and MTP-EN can be easily fitted using the “glmnet” R package (Friedman
et al., 2010), specifying the weights in the penalty.factor argument of the cv.glmnet function.
However, there remains the problem of choosing the penalties of all ’omic layers except the first one.
IPF-LASSO has recently been extended by Zhao and Zucknick (2020) to combine it with the
tree-guided group LASSO of Kim et al. (2012) for which the grid search-type approach proposed by
Boulesteix et al. (2017) is not a viable option, given its high computational cost. Therefore, they
use the efficient parameter selection via global optimisation (EPSGO) algorithm of Fröhlich and
Zell (2005) instead (details of the algorithm are given in Section 2.3). In the same manuscript, Zhao
and Zucknick (2020) also give a more flexible formulation of the structured penalised regression
model of Liu et al. (2018) that allows different values of the parameter α for each layer:
min
β0∈R, β∈RP1+···+PM
− l(X,y;β0,β) + λ1N1(β1) + · · ·+ λMNM (βM ) (9)
where Nm(βM ) = (1− αm)‖βm‖2 + αm‖βm‖1.
Zhao and Zucknick (2020) call the model of Liu et al. (2018) sIPF-EN (where the “s” stands for
“simple”), and this new, more general one, IPF-EN. This is the naming convention that is used in
the remainder of this manuscript.
2.3 Efficient parameter selection via global optimisation
We provide a short introduction to online Gaussian processes, which are central to the EPSGO
algorithm, and then describe the EPSGO algorithm in more detail.
2.3.1 Online Gaussian processes
A Gaussian process (GP) is a collection of random variables, any finite number of which have a
joint Gaussian distribution (Rasmussen and Williams, 2006).
A GP is fully specified by its mean function µ : X → R and covariance function κ : X × X → R.
Here we assume that X ⊆ RD. Given a finite sample of points x = [x1, . . . , xN ], the GP provides
a probabilistic model for the function q(x). For this reason, Gaussian processes are often used as
priors on functions. We indicate this by
q ∼ GP(µ, κ). (10)
For simplicity, the mean function is often considered to take value zero on the entire domain, without
loss of generality.
Typically one does not observe exactly q(x), but has instead available noisy observations of q(x),
which we denote as
y = q(x) + Ô, (11)
where Ô is independent and identically distributed (i.i.d.) noise with variance σ2Ô . Equivalently, we
can write
y|x ∼ N
(
0, k(x,x) + σ2Ô I
)
(12)
where I is the identity matrix.
Using standard properties of Gaussian distributions, one can show that, given a set of N data
points DN = {d1, . . . , dN}, where dn = (xn, yn), the predictive distribution conditioned of DN is
also Gaussian:
q(xnew)|xnew,DN ∼ N (µN (xnew),KN (xnew,xnew)) . (13)
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for any finite set of points xnew = [xnew1 , . . . , xnewN ] where the conditional mean vector µN and
covariance matrix KN , are available in closed form (Rasmussen and Williams, 2006, Chapter 2).
From the definition of GP, it follows that the posterior distribution q is a Gaussian process:
q|Dτ ∼ GP(µτ , kτ ). (14)
The predictive distribution can also be updated in an iterative fashion using Bayes’ rule. Having
observed N data points, once a new data point dt+1 is available, the updated predictive distribution
is:
pN+1(ynew|dN+1) = p(dN+1|y
new)pˆ(ynew)∫
p(dN+1|y)pˆ(y)dy . (15)
Here the integral in the denominator is intractable, so the predictive distribution after observing N
points is denoted by pˆN to indicate that only an approximation is available.
Both the expected model value µˆN (x) and the estimated variance of the model σˆ2N (x) can be
evaluated by recursive formulae that can be easily updated as soon as a new data point is available
(Csató and Opper, 2002).
2.3.2 The EPSGO algorithm
The EPSGO algorithm was initially developed by Fröhlich and Zell (2005) to efficiently tune the
parameters of support vector machines (SVMs) and subsequently used by Sill et al. (2014) to select
the parameters α and λ of EN (Equation 2). The implementation of Sill et al. is used in the R
package “IPFStructPenalty” of Zhao and Zucknick (2020) to tune the parameters of sIPF-EN and
IPF-EN.
The idea is to reframe the task of tuning the model parameters as an optimisation problem.
Denoting by X the parameter space of the model of interest, and by q : X ⊆ RD → R a measure of
the quality of the model, in the case of logistic regression models, this can be the out-of-sample
misclassification rate (MR). The goal is to find the parameters x∗ such that
x∗ = arg min
x∈X
q(x). (16)
To do so, the EPSGO algorithm models the prior on the error surface q on the parameter space X
as a Gaussian process.
In the first step of the algorithm, some points are sampled from the parameter space that are
used to fit an online GP. In order to obtain a good coverage of the parameter space X , the Latin
hypercube sampling strategy of McKay et al. (1979) is used. The recommended number of points
to be sampled at this stage is N = 10D.
Once the online GP has been fit on a set of N points, the improvement function is defined as
I(x) = max {qmin − Y, 0} . (17)
where qmin indicates the smallest value of the function q observed up to the current iteration and
Y ∼ N (µˆN , σˆN ). A new point xnew in the parameter space X is chosen so as to maximise the
expected improvement criterion of Jones et al. (1998):
xnew = arg max
x∈X
E[I(x)]. (18)
and the online GP is updated after evaluating the error surface at xnew. This procedure is repeated
until convergence is reached.
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2.4 Penalised logistic regression for multi-omic data
We propose two ways of doing penalised logistic regression on multi-omic data: (1) separate EN on
each layer with fixed α; and (2) separate EN on each layer where α is selected via EPSGO.
1. Separate EN on each layer with fixed α First, a variable selection step is performed on
each ’omic layer separately using EN with a fixed value of α. The selected variables are then used
to build a predictive model using ridge-penalised logistic regression. All regression models are fitted
using the “glmnet” R package and the values of λ in each model are selected via CV. The value of α
should be chosen depending on the particular application; here we explore how the performances of
the method change for different values of α. For our simulation studies and real data analysis we
find α = 0.1 to be a reasonable value.
2. Separate EN on each layer, α selected via EPSGO The difference between this method
and the previous one is that the EPSGO algorithm is used in the first step to pick an optimal
value for α in each ’omic layer. This can be convenient when the user does not have a particular
preference for the value of α. However, we show in Section 4.1.1 that this approach is not always
preferable to the previous one.
3 Simulation study
We perform a simulation study in order to compare the two approaches presented in the previous
section to their main competitors: naïve EN and sIPF-EN, detailed below. To this end, we
modify the implementations of naïve EN and sIPF-EN of the R package “IPFStructPenalty”, which
currently only handles linear regression, in order to do logistic regression. The two other methods
are implemented from scratch, heavily relying on the “glmnet” and “IPFStructPenalty” R packages.
We also consider a univariate approach. The code used to produce all the results presented below is
available at https://github.com/acabassi/logistic-regression-for-multi-omic-data.
Naïve EN This is the original EN algorithm (Equation 2) applied to all the ’omic layers stacked
together. We make use of the EPSGO algorithm to automatically select the best value of α, while λ
is chosen via CV.
sIPF-EN As mentioned in Section 2.2, this is a variation of EN that assigns different penalty
factors λ to each layer, but selects the same value of α for each of them (Zhao and Zucknick, 2020).
Univariate approach For each ’omic variable, a logistic regression model is built where the only
predictors are the variable of interest, and, where appropriate, any covariates that are known to be
related to the outcome and therefore are always included in the model. If the null hypothesis that
the regression coefficient of the variable of interest should be zero is rejected, then that variable is
selected. A ridge-penalised regression model is then built using all the selected variables as well as
the covariates that are always included in the model.
3.1 Simulation settings
Our simulation settings are similar to those of Boulesteix et al. (2017). We generate three layers
of data for each experiment, with N = 100 observations each. The first layer represents a set of
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clinical covariates that are known to be related to the outcome of interest, and for this reason are
not penalised. The other two layers represent two ’omic datasets with varying numbers of covariates
and proportions of covariates that are correlated with the outcome. We denote the number of
non-penalised covariates by PN , the number of variables in the first and second penalised layers
by P1 and P2 respectively. Each has a small number of relevant variables, denoted by P r1 and P r2
respectively.
In each dataset, the responses are drawn independently from a Bernoulli distribution with
parameter τ = 0.5. The variables are then drawn from the following multivariate Gaussian
distributions:
[X1, . . . , XPN+P1+P2 ]
T |Y = 0 ∼MN (0PN+P1+P2 ,Σ), (19)
[X1, . . . , XPN+P1+P2 ]
T |Y = 1 ∼MN (µPN+P1+P2 ,Σ), (20)
where
µ = [β1, . . . , β1, 0, . . . , 0, β2, . . . , β2, 0, . . . , 0] (21)
with P r1 elements of µ equal to β1 and P r2 elements equal to β2. The covariance matrix Σ is either
the identity matrix
Σ0 = IPN+P1+P2 (22)
or a block diagonal matrix similar to the one considered in the simulation studies of Boulesteix et al.
(2017) and Zhao and Zucknick (2020) that we indicate with Σ1. The penalised layers have blocks of
correlated variables both within and across layers. All the non-penalised covariates are correlated,
but uncorrelated to the penalised ones. That is
Σ1 =

N
A1 B12
A1 B12
. . . . . .
A1 B12
B21 A2
B21 A2
. . . . . .
B21 A2

(23)
where b = 10, N , A1 and A2 are matrices of size PN ×PN , P1/b×P1/b, and P2/b×P2/b respectively
with ones on the diagonal and all other elements equal to ρ and B12 and B21 are matrices of size
P1/b× P2/b and P2/b× P1/b respectively with all elements equal to ρ.
We consider the same sets of values for P1, P2, P r1 , P r2 , β1, β2 as Boulesteix et al., reported in
Table 1. Moreover, we set PN = 2 and βN = β1. The value of ρ is equal to 0.4 in all simulation
settings, as in Boulesteix et al.
In the Supplementary Material we consider three additional sets of simulation settings. In the
first one, only the two ’omic layers are included in the regression. In the other two, we consider
again the same simulation scenarios presented here, but with PN = 10 and PN = 100. We also
compare these methods to a different univariate selection method followed by a ridge regression on
the selected variables.
3.2 Simulation results
Figures 1 and 2 show the outcome of the simulation studies. For each setting and each algorithm, we
report the following quantities: the MR on the test set, the MR on the training set, the number of
8
ll
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l l
l
ll
ll
l
l
l
l
l
l
ll
l
l
l
l
l
l
l l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
ll
l
ll
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
lll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
Setting A Setting B Setting C Setting D Setting E Setting F
M
R
M
R
 CV
N
. selected va
r
.
Precision
R
ecall
N
aï
ve
Se
pa
ra
te
 / 
EP
SG
O
Se
pa
ra
te
 / 
Fi
xe
d 
al
ph
a
sI
PF
Un
iva
ria
te
N
aï
ve
Se
pa
ra
te
 / 
EP
SG
O
Se
pa
ra
te
 / 
Fi
xe
d 
al
ph
a
sI
PF
Un
iva
ria
te
N
aï
ve
Se
pa
ra
te
 / 
EP
SG
O
Se
pa
ra
te
 / 
Fi
xe
d 
al
ph
a
sI
PF
Un
iva
ria
te
N
aï
ve
Se
pa
ra
te
 / 
EP
SG
O
Se
pa
ra
te
 / 
Fi
xe
d 
al
ph
a
sI
PF
Un
iva
ria
te
N
aï
ve
Se
pa
ra
te
 / 
EP
SG
O
Se
pa
ra
te
 / 
Fi
xe
d 
al
ph
a
sI
PF
Un
iva
ria
te
N
aï
ve
Se
pa
ra
te
 / 
EP
SG
O
Se
pa
ra
te
 / 
Fi
xe
d 
al
ph
a
sI
PF
Un
iva
ria
te
0.2
0.4
0.6
0.0
0.2
0.4
0.6
0
300
600
900
0.00
0.25
0.50
0.75
1.00
0.00
0.25
0.50
0.75
1.00
Figure 1. Simulation study comparing different variants of EN for multi-omic data.
The covariance matrix used here is the diagonal matrix Σ0. “MR” is the out-of-sample
misclassification rate, “MR CV” the within-sample misclassification rate. The non-penalised
covariates are not included when computing precision and recall.
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Figure 2. Simulation study comparing different variants of EN for multi-omic data.
The covariance matrix used here is the block matrix Σ1. “MR” is the out-of-sample
misclassification rate, “MR CV” the within-sample misclassification rate. The non-penalised
covariates are not included when computing precision and recall.
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PN P1 P2 P
r
1 P
r
2 βN β1 β2
Setting A 2 1000 1000 10 10 0.5 0.5 0.5
Setting B 2 100 1000 3 30 0.5 0.5 0.5
Setting C 2 100 1000 10 10 0.5 0.5 0.5
Setting D 2 100 1000 20 0 0.3 0.3 -
Setting E 2 20 1000 3 10 1 1 0.3
Setting F 2 20 1000 15 3 0.5 0.5 0.5
Table 1. Values of PN , P1, P2, P r1 , P r2 , βN , β1, β2 used for the simulation study.
selected variables minus the number of non-penalised covariates, the proportion of selected variables
that are among the relevant ones, excluding the non-penalised covariates (precision), the proportion
of relevant variables that are selected by the algorithm, excluding the non-penalised covariates
(recall).
Figure 1 shows that, when the covariates are uncorrelated, all methods have comparable out-of-
sample MRs, except in settings E and F where the MR is slightly higher for the naïve approach
and slightly lower for sIPF-EN. The within-sample MR is lower for the separate with EPSGO and
separate with fixed α methods, suggesting that those two might be prone to overfitting. Concerning
the precision, there is no clear pattern throughout settings. On the contrary, the two instances
of separate regression on each layer consistently show higher values of the recall. Unsurprisingly,
the same two algorithms also select the highest number of variables in all settings. This behaviour
is opposite to that of the univariate method, which selects a very low number of variables and
therefore has values of the recall always close to zero.
In Figure 2, we see that if the covariates are correlated, sIPF-EN has the lowest MR, thanks to
the fact that, contrarily to the other methods, it takes into account the correlation between data
layers. The only other method that does this is naïve EN, however, assigning the same penalty to all
layers puts this method at a disadvantage in the settings where the two layers are highly unbalanced
(i.e. settings D, E and F). In those settings, the MR of the two-step approaches is comparable if
not better than that of naïve-EN. Again, the within-sample MR suggests that the two algorithms
that perform variable selection on each layer separately may be overfitting. As above, the same
two methods select the highest number of variables. This is reflected in lower precision and higher
recall, on average. As expected, the univariate approach has the worst performance overall.
4 Application to cardiometabolic syndrome data
Cardiometabolic syndrome (CMS) is a combination of metabolic dysfunctions such as abdominal
obesity, high levels of fasting glucose, elevated blood pressure, low-level inflammation, high level
of “bad” cholesterol, and low level of “good” cholesterol. While the exact causes of CMS are not
known, it has been shown to be associated with higher risk of type 2 diabetes and cardiovascular
disease (Grundy et al., 2005).
Here we seek to identify a set of molecular features that characterise CMS by integrating multiple
’omic layers. This can give insights into the molecular mechanisms driving the development of
this disease and identify relevant biological markers. Moreover, these can be used to stratify the
undiagnosed population for their probability of being affected by CMS.
We consider the data of Seyres et al. (2020), which contain multiple ’omic datasets as well as a
set of anthropometric and biochemical parameters for:
• 185 non-obese and non-diabetic blood donors, recruited amongst the UK’s National Health
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Service Blood and Transplant donors;
• 10 patients affected by familial partial lipodystrophy syndrome, which is characterised by
loss of subcutaneous fat, cared for by the National Severe Insulin Resistance Service at
Addenbrooke’s Hospital in Cambridge;
• 10 morbidly obese individuals (BMI greater than 40), who were referred for bariatric surgery
by the Obesity Clinic of Addenbrooke’s Hospital in Cambridge.
For each individual, ChIP-seq, RNA-seq data, and DNA methylation data were collected from
two types of white blood cells: monocytes and neutrophils. In addition to that, metabolites and
lipids were measured from plasma. The ChIP-seq dataset contains 25,600 and 26,300 peaks for
monocytes and neutrophils respectively. The RNA-seq dataset contains 10,433 genes for monocytes
and 20,597 for neutrophils. The DNA methylation dataset has values for 26,214 CpG sites in
the monocytes and 21,442 in neutrophils. The metabolite and lipid datasets contain 988 and 123
features respectively.
Based on their clinical parameters, we select 16 donors as controls. These are considered to be
healthy people and, together are referred to as “controls” in the remainder of this manuscript. More
details, including data processing and consideration of batch effects, can be found in Seyres et al.
(2020).
4.1 Multivariate signature identification
This section is dedicated to the multivariate analysis of the CMS data. In Section 4.1.1 we select the
variables that help distinguish obese individuals from healthy people, using the penalised logistic
regression methods presented in Section 2.2. In Section 4.1.2 we use the selected variables to estimate
the probability of each blood donor of belonging to the class of obese individuals. In Section 4.2 we
repeat the analysis, this time comparing lipodystrophy patients to healthy donors.
4.1.1 Signature identification
Because we are interested in identifying the variables that help discriminate between healthy people
and CMS patients, we choose the two algorithms that have the highest recall in our simulation
settings, which are those that perform variable selection by training a separate EN model on each
layer. Moreover, contrarily to the other methods, these have the advantage of selecting a set of
features in each layer that together are predictive of patient status. This allows us to identify a
molecular signature of CMS in each layer.
In this section, first we explain how the available samples are divided into training and test sets.
Then, we present the results obtained with a fixed value of α, explaining the rationale behind the
choice of the value 0.1. Finally, we comment on the results obtained choosing the value of α as
suggested by Zhao and Zucknick (2020) and explain why fixing the value of α turns out to be more
convenient for our application.
Training and test sets We consider the following comparisons: obese individuals versus controls
and lipodystrophy patients versus controls. Each of these defines a different split of our training set
into healthy people (controls, labelled by “0” in our logistic regression) and individuals affected by
lipodystrophy or obesity (cases, label “1”) and helps extracting the most relevant features for each
comparison. In this section we only present the results obtained for the first comparison; results for
the second comparison are reported in Section 4.2.
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Separate EN on each layer with fixed α We use separate EN on each layer with fixed α to
identify putative multivariate signatures that discriminate between the considered groups. Before
doing so, we centre and scale each dataset so that all variables have mean 0 and variance 1 across
the individuals in which they were measured.
The training set is formed by the donors who have been selected as controls and the obese
individuals. We use 10-fold CV as suggested by Zou and Hastie (2005). To do so, we use the
cv.glmnet function of the R package “glmnet”. Since different CV splits result in different subsets
of selected variables, we repeat the CV procedure 1000 times for each layer, and then consider
the largest set of selected variables and the set of variables that is selected most often. We notice
that the latter only contains a few variables, if any, and that many of the selected variables are in
common between the two (see Supplementary Material), so we decide to keep the former. Repeating
the analysis for α = 1, 0.5 and 0.1, which roughly corresponds to having high, medium, and low
amount of selection, the two highest values of a lead to selecting very few, if any, variables in most
layers (Figure 3). For this reason, we decide to pick α = 0.1. Note that, in this setting, despite
giving relative weight of only 10% to the LASSO penalty, a tiny percentage of the available variables
is selected.
Figure 3 shows, for each ’omic layer, the average value of each selected variable for each category
of people: donors who have been selected as controls, the remaining donors, obese individuals
and lipodystrophy patients. As we might expect, the average values taken by each variable have
opposite signs in the two sets of people used in the training set. Perhaps more interestingly, we note
that, while the other donors have average values that are close to zero, lipodystrophy patients take
extreme values on most of the selected variables. On top of those values, red bars indicate which
variables are selected for each value of α. The variables that are not selected for any value of α are
not shown.
Comparison with separate EN with α selected by EPSGO We now apply the same strategy
as above, except that we let the EPSGO algorithm choose α so as to minimise the MR. The first
step of the EPSGO algorithm fails on the lipid data. For this reason the results presented here only
comprise the remaining seven ’omic layers.
Table 2 shows the number of selected variables in each layer by each method, as well as the
selected value of α and the number of selected variables that are in common between the two
algorithms. The optimal values of α selected via error surface optimisation are all higher than
0.1, except for the metabolite data. Consequently, fewer variables are selected compared to fixing
α = 0.1. While in some cases this may be a desirable feature, here it makes it difficult to identify
molecular signatures, especially for the ChIP-seq data of monocytes, where only one variable is
selected.
Therefore, the automatic selection of α via the EPSGO algorithm presents two main disadvantages
in applications like ours. The first and most important one is that the algorithm may not always
work, as it is the case for the lipid data. Secondly, selecting the EN parameter so as to minimise the
average out-of-sample error can be quite convenient in some cases, it may not be the best choice in
applications where the goal is to select a reasonable number of predictive features in each dataset.
4.1.2 Probability of being affected by cardiometabolic syndrome
After performing variable selection on each layer separately, we train a ridge-penalised logistic
regression model on the matrix formed by all the variables selected in each layer to compute the
probability of belonging to the case group for each individual. The training and test sets are the
same as in Section 4.1.1. Again, we present here the results obtained for the comparison between
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Figure 3. Variables selected with separate EN and fixed α, for different values of the
parameter α. The red bars indicate which variables are selected with α = 1, 0.5 and 0.1
respectively. Below are shown the average values of those variables for the donors and
controls and for the lipodystrophy and obese individuals. Only the variables selected for at
least one of those values are reported here.
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# variables
α = 0.1
# variables
EPSGO
α
EPSGO ∩
ChIP-seq monocytes 428 1 0.59 1
ChIP-seq neutrophils 611 40 0.75 29
RNA-seq monocytes 425 111 0.96 21
RNA-seq neutrophils 592 219 0.13 82
Methylation monocytes 106 31 0.75 0
Methylation neutrophils 25 54 0.59 5
Metabolites 60 195 0.02 55
Lipids 62 - - -
Table 2. Comparison of separate EN methods. From left to right, are reported: the
number of selected variables when α = 1, the number of selected variables when α is selected
using EPSGO, the value of α picked by EPSGO, and the number of variables that are
selected both with fixed α and with α selected via EPSGO.
obese individuals and controls; the results for the lipodystrophy patients versus controls case can be
found in Section 4.2.
Figure 4 shows, for each person, the probability of belonging to the extreme phenotype group
(which in this case comprises the obese individuals). The probabilities estimated on each layer
separately are also reported. These are derived by fitting a logistic regression with l2 penalty on
the selected variables only. The ChIP-seq and RNA-seq data give similar predictions, while the
lipidomics dataset produces slightly different ones. For the methylation and metabolomics datasets,
the probabilities of being a case do not differ greatly among individuals.
It is interesting to note that the lipodystrophy patients have higher probabilities of belonging to
the same class as the obese individuals than the blood donors. This suggests that, on the molecular
level, lipodystrophy patients are more similar to obese people than the average person. This is not
surprising, as those two conditions are characterised by similar biochemical and clinical profiles. On
the other hand, some blood donors have very similar predicted values to the obese and lipodystrophy
individuals. This may indicate that blood donors can show similar characteristics to those in the
extreme phenotype groups, which could provide insights into the pathogenesis of CMS.
These peculiarities of the results can be better observed by assigning a ranking to each person
from 1 to 96 based on their probability of belonging to the class with label “1”, where the person
with rank 1 has the highest probability. We do this based on the probabilities estimated on each
layer separately, and then take the average as the aggregated rank for each person. Note that
this combined ranking does not correspond to the ranking implied by the probabilities of class
membership obtained using the full ridge-penalised model (Figures 4a, 4c, and 4e).
Many other ways of combining the rankings could have been considered. The literature on rank
aggregation is vast; the first efforts on this topic date back to the XVIII century (de Borda, 1781).
This is still a thriving field in modern times, with a wide range of rank aggregation methods being
developed for different types of applications, including genomic and multi-omic studies (Blangiardo
and Richardson, 2007, Lin and Ding, 2009). An overview is provided by Lin (2010). Due to the
fact that, as we have seen, data available for these studies often have missing values, the focus has
recently shifted to methods that can handle partial rankings (Aerts et al., 2006, Kolde et al., 2012).
A comparative study of such methods has been performed by Li et al. (2019). However, we find
that, in this simple case, taking the average ranks is a sensible choice.
Figure 4 also shows the rankings obtained on each dataset separately and those computed
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by combining all the partial rankings together. Again, some of the lipodystrophy patients score
similarly to the obese individuals. Moreover, we find some donors among the lipodystrophy patients.
4.2 Lipodystrophy patients versus control donors
Figure 5 shows the average values of the selected variables for the second comparison (lipodystrophy
patients versus control donors). Interestingly, lipodystrophy and obese individuals have similar
average values in neutrophils for ChIP-seq and RNA-seq data, but the same is not true for the other
datasets.
In Figure 6 are reported the probabilities of being a case, i.e. lipodystrophy patient, for each
individual and each layer, as well as those given by a ridge regression on the clinical covariates. The
probability given by the full model including all the selected variables is also reported. Moreover,
the rankings of each person by probability of being a case for each layer and the set of clinical
covariates are reported, together with the final, average ranking. The results are comparable to
those obtained when using the obese individuals for the training set, where all patients have high
probabilities and rankings.
4.3 Interpretation of results
While it might be interesting to use models like the one presented here to identify donors affected
by CMS, the results presented in this work cannot be used for diagnostic purposes and should be
considered as explorative. This is because the sample size is quite small, especially compared to
the large number of covariates considered. Widely accepted practices for studies where prediction
models are developed, validated or updated for prognostic or diagnostic purposes are those outlined
by Moons et al. (2015), which are summarised into the TRIPOD checklist. Moreover, Riley et al.
(2020) give precise indications for sample size calculation in clinical prediction models. To build a
predictive model that can be used in the clinic, one would need to collect data in compliance with
those guidelines.
5 Conclusion
We proposed two new ways of building binary predictive models for multi-omic datasets with the
aim of retrieving as many relevant predictive variables as possible. The variables are selected via EN
on each ’omic layer separately, allowing the user to either have the freedom to choose the amount of
selection, manually selecting the value of the parameter α, or automatically selecting the value of α
that minimises the MR. We compared these two methods to the two main competitor methods for
multi-omic logistic regression that use a EN-type penalty, and to a univariate approach. From our
simulation studies, we concluded that there is no one-size-fits-all approach that is able to achieve
low MR in all settings as well as high precision and recall. However, our two suggested methods
give higher values of the recall in all simulation settings, so they should be preferred in contexts
where the interpretability of the model is key. We presented a real data analysis of cardiometabolic
syndrome data, showing that our approach is able to discriminate between healthy donors and CMS
patients and that it selects variables that are predictive of this syndrome, at least in two of the
eight available layers. Molecular signatures of CMS are identified in each omic layer, which can be
used to guide the identification of new diagnosis and treatment strategies.
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Figure 4. Probabilities of belonging to the class of obese individuals and ranking of
each person according to those probabilities. Both quantities are shown on each dataset
separately and considering all the data types jointly. The model is trained on the obese
individuals and control donors. Each column corresponds to one of the individuals who
have no missing data, each row corresponds to one of the layers. The columns are sorted
by probability of being a case in (a), (c), and (e) and final ranking in (b), (d), and (f). All
rankings are divided by the total number of observations.
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(a) ChIP-seq, monocytes and neutrophils.
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Figure 5. Signature identification. Penalised logistic regression model trained on the
lipodystrophy patients and control donors. Average values of the selected variables for each
group of people. Each column corresponds to one of the selected variables.
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Figure 6. Probabilities of belonging to the class of lipodystrophy patients and ranking of
each person according to those probabilities. Both quantities are shown on each dataset
separately and considering all the data types jointly. The model is trained on the lipodys-
trophy patients and control donors. Each column corresponds to one of the individuals who
have no missing data, each row corresponds to one of the layers. The columns are sorted
by probability of being a case in (a), (c), and (e) and final ranking in (b), (d), and (f). All
rankings are divided by the total number of observations.
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Supplementary Material
In this Supplementary Material, we include details that were omitted from the main paper for
the sake of brevity. In Section A we report the results of additional simulation studies and give
more details about the choice of the parameter α for the first of our proposed approaches, where
α is kept fixed. In Section B we present the outcome of the real data analysis presenting some
additional output of the comparison between obese patients and healthy donors.
A Additional simulation studies
We present here the results of two additional simulation settings. In the first one, only two penalised
layers are combined. The second one is similar to the one presented in Section 3.2 of the main
paper, with the number of penalised covariates increased from two to ten and 100.
A.1 Penalised covariates only
The parameters of the additional simulation study presented here are the same as those presented in
Table 1 of the main paper, except that here PN = 0 in all settings. In this case the two covariance
matrices simplify to:
Σ0 = IP1+P2 (1)
and
Σ1 =

A1 B12
A1 B12
. . . . . .
A1 B12
B21 A2
B21 A2
. . . . . .
B21 A2

(2)
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Since there are no covariates that are not penalised here, we also add the results obtained
with a different univariate method. The idea is that for each variable a Mann-Whitney test is
performed: if significant differences are observed between the two classes with confidence level
0.05, after adjusting for multiplicity using the Benjamini-Hochberg procedure, then that variable is
selected. The variables selected in this way are then used to fit a ridge-penalised regression model.
In addition to that, for each method in each setting, we report the number of datasets for which
each method is run successfully. When sIPF it fails, this is due to the fact that all evaluations
of the error surface have the same value. Results for the datasets affected by this problem are
missing; these are only a small fraction of the total number of the generated datasets. Moreover,
the 2-step methods that fit a ridge regression model on the selected variables fail when only one
variable is selected, since the “glmnet” implementation of logistic regression does not work with
only one regressor.
The results are shown in Figures 1 and 2. In the case of diagonal covariance, naïve EN has
higher MR, both within and out-of-sample. The number of variables selected by this method is
extremely low, so it is not surprising to observe higher precision and lower recall compared to the
other methods. The low number of selections is due to the fact that naïve-EN, like sIPF-EN, it is
able to identify sets of features from different layers that together are predictive of outcome status.
The separate EN-type methods have very low values of within-sample MR, but similar values of
out-of-sample MR to sIPF-EN in the first four settings. In the last two settings, which are highly
unbalanced, sIPF-EN greatly outperforms the other two algorithms both in terms of out-of-sample
MR and precision. In the non-diagonal covariance case, similar outcomes are observed. The main
difference is that naïve-EN has lower MN and higher recall in this setting. In both cases, the two
univariate methods behave similarly, selecting fewer variable than the other methods (as expected)
and achieving a low MR only in Setting E.
A.2 Higher number of non-penalised covariates
We repeat the experiments presented in the main paper, replacing the value of PN by 10 (Figures 3
and 4) and 100 (Figures 5 and 6).
The patterns are similar to those observed in the main paper, with the number of selected
variables and values of the recall becoming more and more different between the joint models
(naïve-EN and sIPF-EN) and the two-step approaches as PN increases. The univariate method
cannot be run in the setting where PN = 100, since the number of predictors is higher than the
number of statistical units in the screening step, and a linear regression model cannot be fit.
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Figure 1. Simulation study comparing different variants of elastic-net for multi-omic data
and two univariate approaches. The covariance matrix used here is the diagonal matrix Σ0
and PN = 0. “MR” is the out-of-sample misclassification rate, “MR CV” the within-sample
misclassification rate. “Univariate” refers to the univariate method presented in the main
paper, “Univariate MW” indicates the univariate Mann-Whitney test.
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Figure 2. Simulation study comparing different variants of elastic-net for multi-omic data
and two univariate approaches. The covariance matrix used here is the block matrix Σ1
and PN = 0. “MR” is the out-of-sample misclassification rate, “MR CV” the within-sample
misclassification rate. “Univariate” refers to the univariate method presented in the main
paper, “Univariate MW” indicates the univariate Mann-Whitney test.
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Figure 3. Simulation study comparing different variants of elastic-net for multi-omic data.
The covariance matrix used here is the diagonal matrix Σ0 and PN = 10. “MR” is the
out-of-sample misclassification rate, “MR CV” the within-sample misclassification rate.
The non-penalised covariates are not included when computing precision and recall.
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Figure 4. Simulation study comparing different variants of elastic-net for multi-omic
data. The covariance matrix used here is the block matrix Σ1 and PN = 10. “MR” is
the out-of-sample misclassification rate, “MR CV” the within-sample misclassification rate.
The non-penalised covariates are not included when computing precision and recall.
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Figure 5. Simulation study comparing different variants of elastic-net for multi-omic data.
The covariance matrix used here is the diagonal matrix Σ0 and PN = 100. “MR” is the
out-of-sample misclassification rate, “MR CV” the within-sample misclassification rate.
The non-penalised covariates are not included when computing precision and recall.
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Figure 6. Simulation study comparing different variants of elastic-net for multi-omic
data. The covariance matrix used here is the block matrix Σ1 and PN = 100. “MR” is
the out-of-sample misclassification rate, “MR CV” the within-sample misclassification rate.
The non-penalised covariates are not included when computing precision and recall.
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A.3 Choice of α
We compare different values of α for the two-step approach proposed in the main paper, where
α is kept fixed. We consider α = 0.1, 0.5 and 1 and all the simulations settings compared so far:
only two penalised layers (Figures 7 and 8), two non-penalised covariates (Figures 9 and 10), few
non-penalised covariates (Figures 11 and 12), and high number of non-penalised covariates (Figures
13 and 14).
The number of selected variables, precision and recall are as expected: the number of selected
variables and the recall decrease while the precision increases as as the value of α is increased. The
MR, however, doesn’t follow a clear pattern. Table 1 shows how the out-of-sample MR varies in
each simulation setting for increasing values of α.
PN 0 0 2 2 10 10 100 100
Covariance Σ0 Σ1 Σ0 Σ1 Σ0 Σ1 Σ0 Σ1
Setting A = ↓ = ↓ ↓ ↑ ↑ ↓
Setting B = ↓ = ↓ ↓ ↓ = =
Setting C = ↓ = ↓ ? ↓ = =
Setting D = ↓ ↑ = = = = =
Setting E ↓ ↓ = = ↑ = = ↓
Setting F ↓ ? = = ↑ ↓ ↑ ↓
Table 1. Variation in the average MR of the separate EN approach with fixed α when the
parameter α is increased.
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Figure 7. Simulation study comparing different values of α. The covariance matrix used
here is the diagonal matrix Σ0 and PN = 0. “MR” is the out-of-sample misclassification
rate, “MR CV” the within-sample misclassification rate.
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Figure 8. Simulation study comparing different values of α. The covariance matrix used
here is the block matrix Σ1 and PN = 0. “MR” is the out-of-sample misclassification rate,
“MR CV” the within-sample misclassification rate.
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Figure 9. Simulation study comparing different values of α. The covariance matrix used
here is the diagonal matrix Σ0 and PN = 2. “MR” is the out-of-sample misclassification
rate, “MR CV” the within-sample misclassification rate.
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Figure 10. Simulation study comparing different values of α. The covariance matrix used
here is the block matrix Σ1 and PN = 2. “MR” is the out-of-sample misclassification rate,
“MR CV” the within-sample misclassification rate.
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Figure 11. Simulation study comparing different values of α. The covariance matrix used
here is the diagonal matrix Σ0 and PN = 10. “MR” is the out-of-sample misclassification
rate, “MR CV” the within-sample misclassification rate.
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Figure 12. Simulation study comparing different values of α. The covariance matrix used
here is the block matrix Σ1 and PN = 10. “MR” is the out-of-sample misclassification rate,
“MR CV” the within-sample misclassification rate.
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Figure 13. Simulation study comparing different values of α. The covariance matrix used
here is the diagonal matrix Σ0 and PN = 100. “MR” is the out-of-sample misclassification
rate, “MR CV” the within-sample misclassification rate. The non-penalised covariates are
not included when computing precision and recall.
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Figure 14. Simulation study comparing different values of α. The covariance matrix used
here is the block matrix Σ1 and PN = 100. “MR” is the out-of-sample misclassification
rate, “MR CV” the within-sample misclassification rate. The non-penalised covariates are
not included when computing precision and recall.
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B Additional data analysis
In this section, additional information on the data analysis presented in the main paper is reported
for the model discriminating between obese patients and healthy donors. The correlations between
the anthropometric and biochemical parameters and the ’omic features for the ChIP-seq, RNA-seq
and methylation datasets are reported in Section B.1. In Section B.2 are compared the variables
selected by the univariate and multivariate approaches. Finally, in Section B.3 we compare the
multivariate approach used in the main paper to the Mann-Whitney test introduced above.
B.1 Signature validation
In order to validate our putative multivariate signatures of CMS, we check whether there is an
association between our selected variables and the anthropometric and biochemical parameters.
To do so, we fit the following regression model, that adjusts for age and sex, for each pair of
anthropometric/biochemical parameter and ’omic measurement:
parameteri = β0 + βage × agei + βfemale × I(femalei) + β’omic × ’omici + Ô, (3)
where i = 1, . . . , N and I is the indicator function. Figure 19 shows the coefficients of the selected
metabolites and lipids in each of these regressions. Those marked with a star correspond to those
for which the null hypothesis is rejected for the test H0 : β’omic = 0 versus H1 : β’omic Ó= 0 at
significance level 0.01. We control the false discovery rate (FDR) by adjusting the p-values using
the Benjamini-Hochberg procedure. The ChIP-seq and methylation variables have no significant
associations, while the RNA-seq only a few (see Supplementary Material).
The coefficients of regression model of Equation (25) for the ChIP-seq, RNA-seq, and methylation
data are shown in Figures 15, 16, and 17. In these datasets, the number of tests that are significant
at level 0.01 after correcting for multiple testing using the Benjamini-Hochberg procedure is low.
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Figure 15. ChIP-seq data.
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Figure 16. RNA-seq data.
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Figure 17. Methylation data.
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Figure 18. Association of the selected metabolites with the anthropometric and biochemical
parameters. Cells marked with a star represent associations that are statistically significant
with a confidence level of 0.01 after correcting for multiple testing using the Benjamini-
Hochberg procedure.
* * * *
* * * *
* * * *
* * *
* * *
* * *
* * * *
* *
* *
* *
* *
* * *
* *
*
*
* *
* *
*
*
*
*
*
*
*
* *
* *
* * *
*
* *
* *
* * * * *
* * * *
* * *
* * *
* * * *
* * * * *
* * * * *
* * * * * *
* * *
* * *
* * *
* *
* *
* * *
* * *
H
D
L
FF
A
LD
L
CH
O
L
AS
T
AL
T
hs
CR
P
G
lu
co
se
W
e
ig
ht
AT
−I
R
In
su
lin
H
O
M
A−
IR
LA
R TG
β−estimate
−1 −0.5 0 0.5 1
Figure 19. Association of the selected lipids with the anthropometric and biochemical
parameters. Cells marked with a star represent associations that are statistically significant
with a confidence level of 0.01 after correcting for multiple testing using the Benjamini-
Hochberg procedure.
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B.2 Comparison of the multivariate and univariate variable selection approaches
In Section 4.2 of the main paper are reported two Venn diagrams representing the intersection
between the number of variables selected by the elastic-net (considering both the median and
maximal sets of variables over multiple runs of 10-fold cross validation) and those selected via
univariate testing.
In Table 2 are indicated the number of variables selected by the multivariate and univariate
analyses, and the cardinality of the intersections between those. Table 3 contains the number of
variables selected by the multivariate and univariate analyses and their intersections.
B.3 Univariate differential analysis
We now compare the multivariate signature identification method described above to a simpler
approach that uses univariate tests. For each of the ’omic dataset considered independently, we
use the Mann-Whitney test (Mann and Whitney, 1947) to test for differences in distribution for
each ’omic variable. In order to control the FDR, we adjust the p-values according the Benjamini-
Hochberg procedure. As we shall see, the univariate approach is more conservative as it provides
control over the false discovery rate. On the other hand, while the multivariate approach selects
variables that are jointly useful for prediction and is therefore more permissive, this is not possible
with univariate methods.
We repeat the analysis for both comparisons considered above: bariatric patients versus controls
and lipodystrophy patients versus controls. The Mann-Whitney test is performed using the
wilcox.test function of the R package stats (R Core Team, 2020); the adjusted p-values are
obtained using the qvalue function of the Bioconductor package qvalue (Storey et al., 2019).
Due to the fact that this test is very conservative and that it cannot take into account synergies
between sets of variables that divide the observations into two groups, the number of selected
variables is very low with respect to the multivariate setting. For example, only 14 tests are
significant in the lipidomics layer, when comparing the obese patients to the control donors, and no
variables show significant differences in any of the other layers. In Figure 20 are shown the number
of variables that have been selected in the lipidomics layer with the multivariate approach (both
choosing the largest set of selected variables and the one that is selected most frequently) which
are compared to those selected by univariate testing. The corresponding information for the other
seven layers can be found in the Supplementary Material.
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Figure 20. Venn diagram showing the intersections between the variables selected in the
lipids layer with the multivariate approach with the maximal and modal set of variables
and those selected via univariate testing.
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